WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1997003683) TREATMENT OF SCLERODERMA AND RELATED DISEASES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1997/003683    International Application No.:    PCT/US1996/011923
Publication Date: 06.02.1997 International Filing Date: 19.07.1996
Chapter 2 Demand Filed:    13.02.1997    
IPC:
A61K 35/14 (2006.01), A61K 47/48 (2006.01), C12Q 1/68 (2006.01), G01N 33/569 (2006.01)
Applicants: FRED HUTCHINSON CANCER RESEARCH CENTER [US/US]; 1124 Columbia Street, Seattle, WA 98104 (US) (For All Designated States Except US).
NELSON, J., Lee [US/US]; (US) (For US Only)
Inventors: NELSON, J., Lee; (US)
Agent: PARMELEE, Steven, W.; Townsend and Townsend and Crew, L.L.P, Two Embarcadero Center, 8th floor, San Francisco, CA 94111 (US)
Priority Data:
60/001,315 21.07.1995 US
Title (EN) TREATMENT OF SCLERODERMA AND RELATED DISEASES
(FR) TRAITEMENT DE LA SCLERODERMIE ET DES MALADIES APPARENTEES
Abstract: front page image
(EN)Allogeneic cells are removed from an individual predisposed to or suffering from scleroderma or related diseases, thereby treating the disease and inhibiting or preventing its recurrence. Allogeneic cells are identified in the individual and treatment tailored to remove such cells, $i(in vivo) or $i(ex vivo), from the individual by cell separation or cytotoxic agents.
(FR)On prélève des cellules allogéniques sur un individu présentant une prédisposition à la sclérodermie ou aux maladies apparentées ou sur un patient déjà atteint, ce qui permet de traiter la maladie et de bloquer ou d'empêcher sa réapparition. On identifie des cellules allogéniques chez l'individu et on applique un traitement personnalisé pour retirer ces cellules, $i(in vivo) ou $i(in vitro), hors de l'organisme de l'individu par séparation cellulaire ou au moyen d'agents cytotoxiques.
Designated States: CA, JP, US.
European Patent Office (AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE).
Publication Language: English (EN)
Filing Language: English (EN)